About Amplifica
Amplifica is a company based in San Diego (United States) founded in 2008 by Wajdie Ahmad, Maksim Plikus, and William Rassman. Amplifica has raised $11.8 million across 1 funding round from investors including SternAegis Ventures. Amplifica offers products and services including AMP-303. Amplifica operates in a competitive market with competitors including Cosmo Pharmaceuticals, Hope Medicine, Triple Hair, AnHorn Medicines and Mallia Therapeutics, among others.
- Headquarter San Diego, United States
- Founders Wajdie Ahmad, Maksim Plikus, William Rassman
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Amplifica Holdings Group, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.8 M (USD)
in 1 rounds
-
Latest Funding Round
$11.8 M (USD), Series A
Oct 24, 2022
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Amplifica
Amplifica offers a comprehensive portfolio of products and services, including AMP-303.
Clinical study targeting hair regrowth via signaling molecules
People of Amplifica
Unlock access to complete
Unlock access to complete
Funding Insights of Amplifica
Amplifica has successfully raised a total of $11.8M through 1 strategic funding round. The most recent funding activity was a Series A round of $11.8 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Amplifica
Amplifica has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include SternAegis Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC and investment banking firm backed by Aegis Capital Corp
|
Locked | Locked | Locked |
Investor details for Amplifica
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Amplifica
Investment portfolio details for Amplifica
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Amplifica
Detailed financials for Amplifica
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Amplifica Comparisons
Peer comparison for Amplifica
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Amplifica
Amplifica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cosmo Pharmaceuticals, Hope Medicine, Triple Hair, AnHorn Medicines and Mallia Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for gastrointestinal diseases are developed and provided.
|
|
| Locked | Locked | Locked |
Monoclonal antibodies are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Developer of treatments for alopecia
|
|
| Locked | Locked | Locked |
Developer of therapeutics for cancer, neurology, and age-related diseases
|
|
| Locked | Locked | Locked |
Developer of therapeutics for hair loss
|
Detailed competitors of Amplifica
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Amplifica
Complete news archive for Amplifica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amplifica
Amplifica was founded in 2008 and raised its 1st funding round 14 years after it was founded.
Amplifica is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Frank Fazio is the current CEO of Amplifica.
Amplifica is a funded company, having raised a total of $11.8M across 1 funding round to date.
Amplifica was founded in 2008 in San Diego, United States, within the biotechnology sector. Therapeutics for androgenic alopecia are developed, focusing on signaling molecules that stimulate dormant hair follicle stem cells to promote hair regrowth. Lead product candidates include AMP-303 and AMP-506, with operations centered on advancing these treatments for clinical applications.
Amplifica's top competitors include Cosmo Pharmaceuticals, Hope Medicine and Triple Hair.
Amplifica offers AMP-303.
Amplifica has 1 investor. Key investors include SternAegis Ventures.